Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07462234 · ClinicalTrials.gov registry record
Continuous N-of-1 Computational Feasibility Study of a Whole Genome Sequence
A clinical trial of Computational Modeling of Individual Metabolic Pathways, sponsored by Bioactify.
- Active
- Registry status
- 1
- Enrollment target
- 1
- Study location
NCT07462234: Active study of Computational Modeling of Individual Metabolic Pathways, sponsored by Bioactify.
NCT07462234 is a study of Computational Modeling of Individual Metabolic Pathways that is active but no longer recruiting, run by Bioactify. The registered enrollment target is 1 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07462234, a study of Computational Modeling of Individual Metabolic Pathways, is active but no longer recruiting, sponsored by Bioactify.
- ACTIVE NOT RECRUITING
- Registry status
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational, computational N-of-1 study that uses previously collected Whole Genome Sequencing (WGS) data from a single adult participant to evaluate the feasibility of a deterministic bioenergetic simulation model. The study does not involve clinical interventions, treatments, or prospective specimen collection. All analyses are performed on existing genomic data in a secure computational environment. The purpose of this study is to determine whether a physics-based metabolic model can successfully integrate individual genomic constraints to generate personalized, hypothesis-driven insights about metabolic pathways. The study focuses on model feasibility and computational performance, not clinical outcomes. No medications, diets, or behavioral interventions are administered or evaluated.
Primary Outcome
Assesses whether secondary 30x Whole Genome Sequencing (WGS) data can be successfully ingested and processed by a deterministic computational framework that incorporates Flux Balance Analysis (FBA) and dynamic physiologically based modeling. Feasibility is defined by the ability to run simulations without system failure, data corruption, or computational instability. This outcome evaluates computational performance only and does not assess clinical endpoints.
Conditions Studied
Study Locations (1)
New York
- Bioactify LLC - Wappingers Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2026-03-05 |
| Est. Completion | 2027-03 |
What the registry record for NCT07462234 still lists
NCT07462234 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 1 condition, with Computational Modeling of Individual Metabolic Pathways appearing as the primary indexed condition, and to 0 interventions.
NCT07462234 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07462234 about?
NCT07462234 is a clinical study titled "Continuous N-of-1 Computational Feasibility Study of a Whole Genome Sequence". This is an observational, computational N-of-1 study that uses previously collected Whole Genome Sequencing (WGS) data from a single adult participant to evaluate the feasibility of a deterministic bioenergetic simulation model. The study does not involve clinical interventions, treatments, or prosp...
What is the current status of trial NCT07462234?
This trial is currently active not recruiting. The enrollment target is 1 participants. The study started on 2026-03-05. Estimated completion is 2027-03.
What conditions does trial NCT07462234 study?
This clinical trial studies the following conditions: Computational Modeling of Individual Metabolic Pathways.
Who is sponsoring clinical trial NCT07462234?
This trial is sponsored by Bioactify, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07462234 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI